Brazil Offering No-Cost PrEP To Help Prevent HIV Among Young People

New York Times: Brazil Fights HIV Spike in Youths With Free Preventive Drug
“Seeking to stem a sharp rise in HIV cases among young people, Brazil began offering a drug this month that can prevent infection to those deemed at high risk of contagion. Brazil is the first country in Latin America, and among the first in the developing world, to adopt the drug, known as PrEP, short for pre-exposure prophylaxis, as an integral part of its preventive health care policy…” (Darlington, 12/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.